Drug Shortage Report for APO-ELETRIPTAN
Report ID | 123558 |
Drug Identification Number | 02386062 |
Brand name | APO-ELETRIPTAN |
Common or Proper name | ELETRIPTAN |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | ELETRIPTAN |
Strength(s) | 40MG |
Dosage form(s) | TABLET TABLET |
Route of administration | ORAL ORAL |
Packaging size | 6 BLS |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-08-31 |
Estimated end date | 2021-11-19 |
Actual end date | 2021-11-18 |
Shortage status | Resolved |
Updated date | 2021-11-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.